Active Pharmaceutical Ingredients (APIs)
|
PRODUCTS |
QUALITY
STD. |
THERAPEUTIC CATEGORY |
TECH.
PACK |
REGULATORY STATUS |
|
US
DMF |
EU
EDMF |
EU
CEP |
JP PDMA |
CA
DMF |
AUS TGA |
|
Human Use |
|
Cinacalcet HCl |
IHS |
Anti-hypeparathyroidism |
√ |
 |
 |
|
|
|
|
|
Darifenacin HBr |
IHS |
Overactive
Bladder |
√ |
|
|
|
|
|
|
|
Desvenlafaxine Succinate |
IHS |
Anti-depressant |
√ |
|
|
|
|
|
|
|
Donepezil HCl Form I |
IHS |
Anti-alzheimer’s
|
√ |
 |
 |
|
|
 |
 |
|
Donepezil HCl
Form III |
IHS |
Anti-alzheimer’s
|
√ |
|
|
|
 |
|
|
|
Memantine HCl |
IHS |
Anti-alzheimer’s
|
√ |
|
|
|
|
|
|
|
Mirtazapine Anhydrous |
USP / EP / IP |
Anti-depressant |
√ |
|
|
|
|
|
|
|
Mirtazapine Hemihydrate |
USP / EP / IP |
Anti-depressant |
√ |
|
|
 |
|
|
|
|
Quetiapine Hemifumarate |
IHS / IP |
Anti-schizophrenia |
√ |
|
|
|
|
|
|
|
Solifenacin Succinate |
IHS |
Overactive
Bladder |
√ |
|
|
|
|
|
|
|
Venlafaxine HCl |
EP |
Anti-depressant |
√ |
|
|
|
|
|
|
|
Ziprasidone HCl |
IHS |
Anti-schizophrenia |
√ |
|
|
|
|
|
|
|
Veterinary Use |
|
Morantel
Citrate
|
IHS |
Anthelmintic |
√ |
|
|
|
|
|
|
|
Morantel
Tartrate
|
IHS |
Anthelmintic |
√ |
|
|
|
|
|
|
|
Oxantel Pamaote
|
IHS |
Anthelmintic |
√ |
|
|
|
|
|
|
|
Pyrantel Pamoate
(Embonate)
|
USP / EP / IP |
Anthelmintic |
√ |
|
|
|
|
|
|
|
Pyrantel Tartate
|
B Vet |
Anthelmintic |
√ |
|
|
|
|
|
|
Note:
"IHS" - In House Specifications "U/C" - Under Compilation
|
Note:
Products protected under specific patents in certain countries are not offered for sale by us in such countries.
APIs Under Development
|
PRODUCTS |
THERAPEUTIC CATEGORY |
|
Bosentan Hydrate |
Pulmonary Artery Hypertension |
|
Dronedarone |
Anti-arrhythmic |
|
Paliperidone |
Anti-schizophrenia |
|
Prasugrel |
Percutaneous Coronary Intervention |
|
Strontium Ranelate |
Anti-osteoporotic |
Email
Print